Advertisement
Advertisement
ORGO
Organogenesis Holdings Inc. Class A Common Stock
1.49
USDSponsored
-0.04
-2.61%
Sep 11, 15:59 UTC -4
Closed
After-Market
1.49
0.00
-0.34%
ORGO Earnings Reports
Positive Surprise Ratio
ORGO beat 20 of 30 last estimates.
67%
Next Report
Date of Next Report
Nov 04, 2026
Estimate for Q3 26 (Revenue/ EPS)
$53.14M
/-$0.17
Implied change from Q2 26 (Revenue/ EPS)
+21.45%
/-76.71%
Implied change from Q3 25 (Revenue/ EPS)
-64.77%
/-213.33%
Organogenesis Holdings Inc. Class A Common Stock earnings per share and revenue
On Aug 06, 2026, ORGO reported earnings of -0.73 USD per share (EPS) for Q2 26, missing the estimate of -0.35 USD, resulting in a -104.48% surprise. Revenue reached 43.76 million, compared to an expected 55.34 million, with a -20.93% difference. The market reacted with a -22.82% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 4 analysts forecast an EPS of -0.17 USD, with revenue projected to reach 53.14 million USD, implying an decrease of -76.71% EPS, and increase of 21.45% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Champions Oncology, Inc.
Report Date
Sep 10, 2026 For Q1 27
Estimate
-$0.01
Actual
-$0.03
Surprise
-194.12%
BioLineRX Ltd
Report Date
Aug 31, 2026 For Q2 26
Estimate
-Actual
-$0.77
Surprise
-
Galmed Pharmaceuticals Ltd.
Report Date
Sep 02, 2026 For Q2 26
Estimate
-$3.18
Actual
$2.86
Surprise
+189.87%
FAQ
What were Organogenesis Holdings Inc. Class A Common Stock's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Organogenesis Holdings Inc. Class A Common Stock reported EPS of -$0.73, missing estimates by -104.48%, and revenue of $43.76M, -20.93% below expectations.
How did the market react to Organogenesis Holdings Inc. Class A Common Stock's Q2 2026 earnings?
The stock price moved down -22.82%, changed from $2.41 before the earnings release to $1.86 the day after.
When is Organogenesis Holdings Inc. Class A Common Stock expected to report next?
The next earning report is scheduled for Nov 04, 2026.
What are the forecasts for Organogenesis Holdings Inc. Class A Common Stock's next earnings report?
Based on 4
analysts, Organogenesis Holdings Inc. Class A Common Stock is expected to report EPS of -$0.17 and revenue of $53.14M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.